Clinical Investigation
Safety of TEE during Structural Cardiac Intervention
Complications Associated With Transesophageal Echocardiography in Transcatheter Structural Cardiac Interventions

https://doi.org/10.1016/j.echo.2022.12.023Get rights and content

Highlights

  • The risk of a TEE-related complication was 3.6% over the past decade.

  • Gastrointestinal hemorrhage is the most frequently reported complication.

  • Intraoperative TEE during cardiac valve surgery had a lower risk of complications.

Background

Transesophageal echocardiograms (TEEs) performed during transcatheter structural cardiac interventions may result in greater complications than those performed in the nonoperative setting or even those performed during cardiac surgery. However, there are limited data on complications associated with TEE during these procedures. We evaluated the prevalence of major complications among these patients in the United States.

Methods

A retrospective cohort study was conducted using an electronic health record database (TriNetX Research Network) from large academic medical centers across the United States for patients undergoing TEE during transcatheter structural interventions from January 2012 to January 2022. Using the American Society of Echocardiography–endorsed International Statistical Classification of Diseases and Related Health Problems Clinical Modifications (10th edition) codes, patients undergoing TEE during a transcatheter structural cardiac intervention, including transaortic, mitral or tricuspid valve repair, left atrial appendage occlusion, atrial septal defect closure, patent foramen ovale closure, and paravalvular leak repair, were identified. The primary outcome was major complications within 72 hours of the procedure (composite of bleeding and esophageal and upper respiratory tract injury). The secondary aim was the frequency of major complications, death, or cardiac arrest within 72 hours in patients who completed intraoperative TEE during surgical valve replacement.

Results

Among 12,043 adult patients (mean age, 74 years old; 42% female) undergoing TEE for transcatheter structural cardiac interventions, 429 (3.6%) patients had a major complication. Complication frequency was higher in patients on anticoagulation or antiplatelet therapy compared with those not on therapy (3.9% vs 0.5%; risk ratio [RR] = 8.09, P < .001). Compared with those patients <65 years of age, patients ≥65 years of age had a higher frequency of major complications (3.9% vs 2.2%; RR = 1.75, P < .001). Complication frequency was similar among male and female patients (3.5% vs 3.7%; RR = 0.96, P = .67). Among 28,848 patients who completed surgical valve replacement with TEE guidance, 728 (2.5%) experienced a major complication.

Conclusions

This study found that more than 3% of patients undergoing TEE during transcatheter structural cardiac interventions have a major complication, which is more common among those on anticoagulant or antiplatelet therapy or who are elderly. With a shift of poor surgical candidates to less invasive percutaneous procedures, the future of TEE-guided procedures relies on comprehensive risk discussion and updating practices beyond conventional methods to minimize risk for TEE-related complications.

Introduction

Transesophageal echocardiograms (TEEs) allow for higher-resolution images of posterior cardiac structures compared with transthoracic echocardiograms, and their diagnostic capabilities have expanded to improved visualization of valvular pathology, workup of recurrent strokes, and evaluation for thromboembolic risk prior to cardioversion in atrial fibrillation.1, 2, 3 More recently, the role of TEE has evolved beyond simple image acquisition to real-time intraoperative visualization utilized to guide percutaneous structural interventions such as transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (MVR), transcatheter tricuspid valve repair (TVR), left atrial appendage occlusion (LAAO), atrial septal defect (ASD) repair, ventricular septal defect (VSD) repair, patent foramen ovale (PFO) repair, and paravalvular leak repair (PVLR).3, 4, 5, 6 Transesophageal echocardiography has been considered a generally safe procedure, with the frequency of major complications ranging from 0.2% to 1.4% in both operative and nonoperative situations; however, it does carry an inherent risk as an invasive imaging technique.7,8 Historically, complications during TEE have been rare injuries to the gastrointestinal tract because of direct mechanical trauma.9,10 With the growing role in structural cases, complications have been more frequently reported secondary to the constant probe manipulation needed during procedures.11,12

There is limited contemporary literature detailing the frequency of complications associated with TEE in transcatheter structural cardiac interventions. The potentially increased risk for TEE-related complications is concerning as we continue to see a dynamic shift to completing percutaneous procedures on these previously poor surgical candidates.13 Over 38,000 LAAOs were completed from January 2016 to December 2018, and over 11,000 transcatheter MVRs were completed in 2019 in the United States.14,15 While smaller studies outside of the United States have reviewed this topic, the frequency of TEE-related complications for transcatheter structural cardiac interventions in the United States has not been previously described.11,12 Additionally, no previous studies have contrasted the frequency of TEE-related complications from intraoperative TEE in cardiac surgery.

The current study aimed to evaluate the short-term complications for U.S. adult patients undergoing TEE for transcatheter interventions that include TAVR, MVR, TVR, LAAO, PVLR, ASD repair, VSD repair, and PFO closure. It also aimed to contrast the frequency of complications seen during cardiac surgery with intraoperative TEE guidance as well.

Section snippets

Data Source

We used the TriNetX (Cambridge, MA) research network database for this study.16, 17, 18, 19, 20, 21, 22 This federated health research network database uses a combination of natural language processing and standardized clinical data entries to integrate electronic health records from multiple institutions into a cloud-based aggregate of nearly 59 million patients. The health entities contributing to the database were composed of approximately 75% academic medical centers and 25% community

Results

We identified 12,043 adult patients who underwent a TEE-guided structural intervention (TAVR, MVR, TVR, LAAO, PVLR, ASD repair, or PFO closure) between January 2012 and January 2022. Figure 1 describes the derivation of the study population and the separate cohort of patients who completed TEE-guided valvular cardiac surgeries. Overall, the geographic distribution of the study population, determined by the location of the health care organization headquarters, was composed of 43.9% (n = 5,284)

Discussion

This study is the first to analyze the outcomes and complications associated with TEE guidance in transcatheter structural cardiac interventions in the United States. It is also the first to contrast the frequency of TEE-related complications between percutaneous interventions and cardiac valve surgery. In this study cohort, 3.6% of patients experienced a major complication. The frequency of major complications in patients undergoing transcatheter structural cardiac interventions was higher

References (50)

  • M. Taquet et al.

    Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

    Lancet Psychiatry

    (2021)
  • A. Nicoara et al.

    Guidelines for the Use of transesophageal echocardiography to assist with surgical Decision-Making in the operating Room: a surgery-based approach: from the American Society of echocardiography in Collaboration with the Society of cardiovascular Anesthesiologists and the Society of thoracic Surgeons

    J Am Soc Echocardiogr

    (2020)
  • E.J. MacKay et al.

    Practice Pattern Variation in the Use of transesophageal echocardiography for open valve cardiac surgery

    J Cardiothorac Vasc Anesth

    (2019)
  • S.K. Kodali et al.

    Valvular heart disease in patients ≥80 Years of age

    J Am Coll Cardiol

    (2018)
  • F. Maisano et al.

    Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe

    J Am Coll Cardiol

    (2013)
  • S. Zahid et al.

    Feasibility and safety of intracardiac echocardiography Use in transcatheter left atrial appendage closure procedures

    J Soc Cardiovasc Angiography Interv

    (2022)
  • M.D. Puchalski et al.

    Guidelines for performing a comprehensive transesophageal echocardiographic: Examination in Children and all patients with Congenital heart disease: Recommendations from the American Society of echocardiography

    J Am Soc Echocardiogr

    (2019)
  • D.R. Holmes et al.

    The heart team of cardiovascular care

    J Am Coll Cardiol

    (2013)
  • F.F. Faletra et al.

    3D TEE during catheter-based interventions

    JACC Cardiovasc Imaging

    (2014)
  • S.R. Bailey et al.

    ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for echocardiography. A report of the American College of cardiology Foundation Appropriate Use Criteria Task Force, American Society of echocardiography, American heart association, American Society of Nuclear cardiology, heart failure Society of America, heart Rhythm Society, Society for cardiovascular Angiography and interventions, Society of Critical care medicine, Society of cardiovascular Computed Tomography, and Society for cardiovascular Magnetic Resonance endorsed by the American College of chest Physicians

    J Am Coll Cardiol

    (2011)
  • G.E. Peterson et al.

    Transesophageal echocardiography: clinical indications and applications

    Circulation

    (2003)
  • J. Ender et al.

    Value of transesophageal echocardiography (TEE) guidance in minimally invasive mitral valve surgery

    Ann Cardiothorac Surg

    (2013)
  • H. Zhang et al.

    Role of real time-three dimensional transesophageal echocardiography in left atrial appendage closure with LACBES® devices

    Exp Ther Med

    (2019)
  • J.N. Hilberath et al.

    Safety of transesophageal echocardiography

    J Am Soc Echocardiogr

    (2010)
  • P. Vignon et al.

    Echecs et complications de l'échocardiographie transoesophagienne. A propos de 1,500 examens consécutifs [Failure and complications of transesophageal echocardiography. Apropos of 1500 consecutive cases]

    Arch Mal Coeur Vaiss

    (1993)
  • Cited by (11)

    • TEE versus ICE for LAAO: Is ICE just as nice?

      2024, Journal of Cardiovascular Electrophysiology
    View all citing articles on Scopus

    Dr. Pankaj Arora is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health, awards R01HL160982, R01HL163852, R01HL163081, and K23HL146887; by the Doris Duke Charitable Foundation COVID-19 Fund to Retain Clinician Scientists (grant no. 2021255); and by the University of Alabama at Birmingham COVID-19 CARES Retention Program (CARES at University of Alabama at Birmingham).

    The research reported in this publication was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award no. UL1TR003096. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

    Conflicts of Interest: None.

    View full text